The Online Investor
Stock Splits
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Apr. 28, 10:45 AM

Slide #2. X4 Pharmaceuticals (NASDAQ:XFOR) 1 for 30 Reverse Split

Announced: 4/24/2025
Stock Split: 1 for 30
Record Date: 4/25/2025
Pay Date: 4/28/2025
XFOR Optionable?: Yes

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4, that is being developed as an oral, once-daily therapy. It has developed a pipeline of small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4).

XFOR SEC Filing Email Alerts Service

XFOR Detailed Information Page & Split History »

Company Name:  X4 Pharmaceuticals Inc
Website:  www.x4pharma.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding XFOR:  23
Total Market Value Held by ETFs:  $91.79M

Open the XFOR Page at The Online Investor (in a new window) »

April 28, 2025    10:45 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree XFOR Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
77th percentile
(ranked higher than approx. 77% of all stocks covered)

Analysts' Target Price:
XFOR Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Stock Splits | www.TheOnlineInvestor.com | Copyright © 1998 - 2025, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.